Gary Patou
CIK 1283535 · Lihat di SEC EDGAR ↗
Orang Dalam
Pengajuan SEC Pertama: 8 Juni 2026 · Terbaru: 8 Juni 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
0 beli (P)
1 jual (S)
Bersih:
$-70.251
+ 82 transaksi non-pasar di bawah
12 bulan terakhir, berdasarkan transaksi yang ditunjukkan di bawah ini
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
82 pengajuan lain disembunyikan
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 5 Juni 2026 | XENE | S 10b5-1 | 1.322 | $53,14 | $70.251 | 24.896 Langsung | -5,04% | Dilepas | 16,0% (harga per 2026-08-20) |
| 22 Nov. 2024 | XENE | S | 2.040 | $41,05 | $83.742 | 23.573 Langsung | -7,96% | Dilepas | 50,2% (harga per 2026-08-20) |
| 22 Nov. 2024 | XENE | S | 2.851 | $41,11 | $117.205 | 23.573 Langsung | -10,79% | Dilepas | 50,0% (harga per 2026-08-20) |
| 14 Des. 2023 | XENE | S | 7.598 | $41,05 | $311.898 | 4.902 Tidak Langsung | -60,78% | Dilepas | 50,2% (harga per 2026-08-20) |
| 13 Des. 2023 | XENE | S | 7.598 | $41,05 | $311.898 | 4.902 Tidak Langsung | -60,78% | Dilepas | 50,2% (harga per 2026-08-20) |
| 13 Des. 2023 | XENE | S | 3.977 | $39,84 | $158.444 | 23.573 Langsung | -14,44% | Dilepas | 54,8% (harga per 2026-08-20) |
| 13 Des. 2023 | XENE | S | 2.303 | $39,10 | $90.047 | 23.573 Langsung | -8,90% | Dilepas | 57,7% (harga per 2026-08-20) |
| 13 Des. 2023 | XENE | S | 5.100 | $38,94 | $198.594 | 23.573 Langsung | -17,79% | Dilepas | 58,4% (harga per 2026-08-20) |
| 25 Nov. 2022 | XENE | S | 1.937 | $34,79 | $67.388 | 23.573 Langsung | -7,59% | Dilepas | 77,2% (harga per 2026-08-20) |
| 23 Nov. 2022 | XENE | S | 2.057 | $34,33 | $70.617 | 23.573 Langsung | -8,03% | Dilepas | 79,6% (harga per 2026-08-20) |
| 10 Agu 2017 | XENE | P | 7.500 | $2,78 | $20.850 | 12.500 Tidak Langsung | +150,00% | Diakuisisi | 2118,2% (harga per 2026-08-20) |
| 8 Agu 2017 | XENE | P | 5.000 | $3,00 | $15.000 | 5.000 Tidak Langsung | — | Diakuisisi | 1955,5% (harga per 2026-08-20) |
| 7 Agu 2014 | PCRX | S 10b5-1 | 20.000 | $100,26 | $2.005.200 | 0 Langsung | -100,00% | Dilepas | -76,0% (harga per 2026-08-20) |
| 14 Juli 2014 | PCRX | S 10b5-1 | 2.107 | $87,58 | $184.531 | 0 Langsung | -100,00% | Dilepas | -72,5% (harga per 2026-08-20) |
| 14 Juli 2014 | PCRX | S 10b5-1 | 27.593 | $86,91 | $2.398.108 | 2.407 Langsung | -91,98% | Dilepas | -72,3% (harga per 2026-08-20) |
| 12 Mei 2014 | PCRX | S 10b5-1 | 10.000 | $75,00 | $750.000 | 0 Langsung | -100,00% | Dilepas | -67,9% (harga per 2026-08-20) |
| 9 Mei 2014 | PCRX | S 10b5-1 | 20.000 | $74,08 | $1.481.600 | 0 Langsung | -100,00% | Dilepas | -67,5% (harga per 2026-08-20) |
| 1 Okt. 2013 | PCRX | S 10b5-1 | 20.000 | $48,92 | $978.400 | 0 Langsung | -100,00% | Dilepas | -50,8% (harga per 2026-08-20) |
Menampilkan 100 dari 114 transaksi terakhir
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 3 Juni 2026 | XENE | Restricted Share Units | Common Shares (1.593) | $0,00 | — | 1.593 | Diakuisisi |
| 3 Juni 2026 | XENE | Share Option (Right to Buy) | Common Shares (10.507) | $53,46 | 2 Juni 2036 | 10.507 | Diakuisisi |
| 1 Juni 2026 | XENE | Restricted Share Units | Common Shares (2.645) | — | — | 2.645 | Dilepas |
| 5 Juni 2025 | XENE | Restricted Share Units | Common Shares (2.645) | $0,00 | — | 2.645 | Diakuisisi |
| 5 Juni 2025 | XENE | Share Option (Right to Buy) | Common Shares (17.012) | $30,73 | 4 Juni 2035 | 17.012 | Diakuisisi |
| 22 Nov. 2024 | XENE | Stock Option (Right to Buy) | Common Shares (3.086) | $13,48 | 3 Mei 2025 | 3.086 | Dilepas |
| 22 Nov. 2024 | XENE | Stock Option (Right to Buy) | Common Shares (3.500) | $7,38 | 1 Juni 2026 | 3.500 | Dilepas |
| 5 Juni 2024 | XENE | Stock Option (Right to Buy) | Common Shares (15.542) | $38,16 | 4 Juni 2034 | 15.542 | Diakuisisi |
| 13 Des. 2023 | XENE | Stock Option (Right to Buy) | Common Shares (5.144) | $9,00 | 3 Nov. 2024 | 5.144 | Dilepas |
| 13 Des. 2023 | XENE | Stock Option (Right to Buy) | Common Shares (2.800) | — | 13 Jan. 2024 | 2.800 | Dilepas |
| 13 Des. 2023 | XENE | Stock Option (Right to Buy) | Common Shares (6.378) | — | 13 Jan. 2024 | 6.378 | Dilepas |
| 2 Juni 2023 | XENE | Stock Option (Right to Buy) | Common Shares (18.475) | $38,96 | 1 Juni 2033 | 18.475 | Diakuisisi |
| 25 Nov. 2022 | XENE | Stock Option (Right to Buy) | Common Shares (2.057) | — | 31 Des. 2022 | 2.057 | Dilepas |
| 28 Juni 2022 | XENE | Stock Option (Right to Buy) | Common Shares (18.000) | $30,11 | 27 Juni 2032 | 18.000 | Diakuisisi |
| 8 Des. 2021 | XENE | Stock Option (Right to Buy) | Common Shares (2.057) | — | 31 Des. 2021 | 2.057 | Dilepas |
| 3 Juni 2021 | XENE | Stock Option (Right to Buy) | Common Shares (10.000) | $18,56 | 2 Juni 2031 | 10.000 | Diakuisisi |
| 28 Okt. 2020 | XENE | Stock Option (Right to Buy) | Common Shares (2.057) | — | 31 Des. 2020 | 2.057 | Dilepas |
| 1 Juni 2020 | XENE | Stock Option (Right to Buy) | Common Shares (10.000) | $13,11 | 31 Mei 2030 | 10.000 | Diakuisisi |
| 4 Des. 2019 | XENE | Stock Option (Right to Buy) | Common Shares (2.057) | — | 31 Des. 2019 | 2.057 | Dilepas |
| 16 Sep. 2019 | XENE | Stock Option (Right to Buy) | Common Shares (15.000) | $9,44 | 15 Sep. 2029 | 15.000 | Diakuisisi |
| 14 Des. 2018 | XENE | Stock Option (Right to Buy) | Common Shares (2.057) | — | 31 Des. 2018 | 2.057 | Dilepas |
| 14 Juni 2018 | XENE | Stock Option (Right to Buy) | Common Shares (8.230) | — | 26 Juni 2018 | 8.230 | Dilepas |
| 4 Juni 2018 | XENE | Stock Option (Right to Buy) | Common Shares (15.000) | $6,20 | 3 Juni 2028 | 15.000 | Diakuisisi |
| 1 Juni 2017 | XENE | Stock Option (Right to Buy) | Common Shares (3.500) | $3,85 | 31 Mei 2027 | 3.500 | Diakuisisi |
| 6 Des. 2016 | XENE | Stock Option (Right to Buy) | Common Shares (12.345) | — | 31 Des. 2016 | 12.345 | Dilepas |
| 2 Juni 2016 | XENE | Stock Option (Right to Buy) | Common Shares (3.500) | $7,38 | 1 Juni 2026 | 3.500 | Diakuisisi |
| 4 Nov. 2015 | XENE | Stock Option (Right to Buy) | Common Shares (3.497) | — | 31 Des. 2015 | 3.497 | Dilepas |
| 4 Mei 2015 | XENE | Stock Option (Right to Buy) | Common Shares (3.086) | — | 3 Mei 2025 | 3.086 | Diakuisisi |
| 7 Jan. 2015 | XENE | Stock Option (Right to Buy) | Common Shares (3.497) | — | 8 Mei 2015 | 3.497 | Dilepas |
| 7 Agu 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (3.524) | $11,68 | 7 Juni 2022 | 3.524 | Dilepas |
| 7 Agu 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (14.364) | $10,81 | 5 Juni 2022 | 14.364 | Dilepas |
| 7 Agu 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (882) | $5,49 | 29 Des. 2020 | 882 | Dilepas |
| 7 Agu 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (1.230) | $1,61 | 2 Sep. 2020 | 1.230 | Dilepas |
| 14 Juli 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (7.303) | $10,81 | 5 Juni 2022 | 7.303 | Dilepas |
| 14 Juli 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (20.237) | $5,49 | 29 Des. 2020 | 20.237 | Dilepas |
| 14 Juli 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (2.460) | $1,61 | 2 Sep. 2020 | 2.460 | Dilepas |
| 3 Juni 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (25.000) | $81,00 | 2 Juni 2024 | 25.000 | Diakuisisi |
| 12 Mei 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (10.000) | $5,49 | 29 Des. 2020 | 10.000 | Dilepas |
| 9 Mei 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (6.836) | $5,49 | 29 Des. 2020 | 6.836 | Dilepas |
| 9 Mei 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (13.164) | $1,61 | 2 Sep. 2020 | 13.164 | Dilepas |
| 1 Okt. 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (20.000) | $1,61 | 2 Sep. 2020 | 20.000 | Dilepas |
| 2 Juli 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (10.000) | $1,61 | 2 Sep. 2020 | 10.000 | Dilepas |
| 1 Juli 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (10.958) | $1,61 | 2 Sep. 2020 | 10.958 | Dilepas |
| 1 Juli 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (19.042) | $1,61 | 2 Sep. 2020 | 19.042 | Dilepas |
| 12 April 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (10.000) | $1,61 | 2 Sep. 2020 | 10.000 | Diakuisisi |
| 1 April 2013 | PCRX | Stock Option (Right to Buy) | Common Stock (30.000) | $1,61 | 2 Sep. 2020 | 30.000 | Diakuisisi |
| 7 Juni 2012 | PCRX | Stock Option (Right to Buy) | Common Stock (60.000) | $11,68 | 7 Juni 2022 | 60.000 | Diakuisisi |
| 5 Juni 2012 | PCRX | Stock Option (Right to Buy) | Common Stock (40.000) | $10,81 | 5 Juni 2022 | 40.000 | Diakuisisi |
| 5 Juni 2012 | PCRX | Director Stock Option (Right to Buy) | Common Stock (40.000) | $10,81 | 5 Juni 2022 | 40.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 15 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 4 Nov. 2014 | XENE | Stock Option (Right to Buy)→ Common Shares | — | Langsung |
| 2 Feb. 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (59.042) | 59.042 | Langsung |
| 2 Feb. 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (59.042) | 59.042 | Langsung |
| 2 Feb. 2011 | PCRX | Stock Option (Right to Buy)→ Common Stock (42.368) | 42.368 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $317.600 | $90.000 | — | $1.477.443 | — | — | — | $1.885.043 |
| 2013 | $317.600 | $50.000 | — | — | — | — | — | $367.600 |
| 2011 | $317.604 | $100.000 | — | — | — | — | $19.056 | $436.660 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.